Sponsor Dossier
Nova Pharmaceuticals
Sponsor Dossier for Nova Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADAPAX
- Brand: ALEZON
- Brand: ALLEXA
- Brand: ALLIVRA
- Brand: AMCAL
- Brand: APIBAX
- Brand: APOHEALTH
- Brand: AURIXIN
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Nasal irrigation saline solution, non-sterile
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Non-sterile scar management dressing, reusable
- Device (sponsor): Adhesive strip, skin-cover
About
Nova Pharmaceuticals is an Australian Private Company with ABN 87 104 838 440, registered in NSW. The entity is active and registered for GST from 2003.
Portfolio
Nova Pharmaceuticals has 98 brands on the ARTG, of which 13 are indexable and 2 carry a Product Information document. 10 brands are PBS-listed, 1 has a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ADAPAX, ALEZON, ALLEXA, ALLIVRA, AMCAL, APIBAX, APOHEALTH, AURIXIN, BETASOOTHE+, BETAVANT, BLACK, BLOOMS THE CHEMIST SORE.
Therapeutic focus
— Pain Management: 21 brands — Dermatology: 17 brands — Cardiology: 12 brands — Infectious Disease: 7 brands — Reproductive Health: 7 brands — Gastroenterology: 6 brands — Complementary Medicine: 6 brands — Respiratory: 6 brands — Endocrinology: 5 brands — Psychiatry: 4 brands — Oncology: 3 brands — Other: 2 brands — Immunology: 1 brand — Renal: 1 brand
PBS footprint
10 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2009-03-01, across 1 brand with a PBAC outcome on record.